FDA.reportPublic FDA data

somapacitan-beco 15 MG in 1.5 ML Pen Injector

RxCUI
2636951
RxNorm name
somapacitan-beco 15 MG in 1.5 ML Pen Injector
Display name
somapacitan-beco 15 MG in 1.5 ML Pen Injector
Full name
somapacitan-beco 15 MG in 1.5 ML Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761156Sogroyasomapacitan-beco351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SOGROYASOMAPACITAN-BECONovo Nordiskeadd03b4-adc3-4b88-8a24-9d205c5b85aa2026-02-25Warnings, Adverse reactionsExact identifier
rxcui: 2636951

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eadd03b4-adc3-4b88-8a24-9d205c5b85aasomapacitan-beco 15 MG in 1.5 ML Pen Injector [PSN] · 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [SCD] · somapacitan-beco 15 MG per 1.5 ML Pen Injector [SY]38These highlights do not include all the information needed to use SOGROYA safely and effectively. See full prescribing information for SOGROYA. SOGROYA ® (somapacitan-beco) injection, for subcutaneous use Initial U.S. Approval: 202020260225